All Stories

  1. Metabolomics Study on Pathogenic and Non-pathogenic E. coli with Closely Related Genomes with a Focus on Yersiniabactin and Its Known and Novel Derivatives
  2. Genome Sequence of the Fish Brain Bacterium Clostridium tarantellae
  3. Molecular Analyses of Over Hundred Sixty Clinical Isolates of SARS-CoV-2: Insights on Likely Origin, Evolution and Spread, and Possible Intervention
  4. Transcriptional and Translational Inhibitors Block SOS Response and Shiga Toxin Expression in Enterohemorrhagic Escherichia coli
  5. Origin and Evolution of Hybrid Shiga Toxin-Producing and Uropathogenic Escherichia coli Strains of Sequence Type 141
  6. Phenotypic and Genotypic Characterization of Escherichia coli Causing Urinary Tract Infections in Kidney-Transplanted Patients
  7. Fimbriae reprogram host gene expression – Divergent effects of P and type 1 fimbriae
  8. Effect of chlorine on cultivability of Shiga toxin producing Escherichia coli (STEC) and β-lactamase genes carrying E. coli and Pseudomonas aeruginosa
  9. Core elements of the vegetative replication control of the Inc1 plasmid pO104_90 of Escherichia coli O104:H4 also regulate its transfer frequency
  10. Antiadhesive hydroalcoholic extract from Apium graveolens fruits prevents bladder and kidney infection against uropathogenic E . coli
  11. Pathophysiology of Escherichia coli pneumonia: Respective contribution of pathogenicity islands to virulence
  12. Characterization of Asymptomatic Bacteriuria Escherichia coli Isolates in Search of Alternative Strains for Efficient Bacterial Interference against Uropathogens
  13. Whole-Genome Draft Sequences of Nine Asymptomatic Escherichia coli Bacteriuria Isolates from Diabetic Patients
  14. Breaching the wall: morphological control of efficacy of phthalocyanine-based photoantimicrobials
  15. Male kidney allograft recipients at risk for urinary tract infection?
  16. Striking an access to the bacteria via (reversible) control of lipophilicity
  17. High Throughput Sequencing for Detection of Foodborne Pathogens
  18. Boronic Acid Functionalized Photosensitizers: A Strategy To Target the Surface of Bacteria and Implement Active Agents in Polymer Coatings
  19. Boronic Acid Functionalized Photosensitizers: A Strategy to Target the Surface of Bacteria and Implement Active Agents in Polymer Coatings
  20. Infection with uropathogenic E. coli induces dynamic epigenetic reprogramming of innate immunity
  21. No evidence for a bovine mastitis Escherichia coli pathotype
  22. Aqueous extract from Orthosiphon stamineus leaves prevents bladder and kidney infection in mice
  23. Zinc treatment is efficient against Escherichia coli α-haemolysin-induced intestinal leakage in mice
  24. The Food Contaminant Deoxynivalenol Exacerbates the Genotoxicity of Gut Microbiota
  25. Host cell interactions of outer membrane vesicle-associated virulence factors of enterohemorrhagic Escherichia coli O157: Intracellular delivery, trafficking and mechanisms of cell injury
  26. No evidence for a bovine mastitis Escherichia coli pathotype
  27. The primary transcriptome of the Escherichia coli O104:H4 pAA plasmid and novel insights into its virulence gene expression and regulation
  28. Long-term survival of the Shiga toxin-producing Escherichia coli O104:H4 outbreak strain on fenugreek seeds
  29. Combined Analysis of Variation in Core, Accessory and Regulatory Genome Regions Provides a Super-Resolution View into the Evolution of Bacterial Populations
  30. Iron Homeostasis Regulates the Genotoxicity of Escherichia coli That Produces Colibactin
  31. Genes on a Wire: The Nucleoid-Associated Protein HU Insulates Transcription Units in Escherichia coli
  32. Whole-Genome Draft Sequences of Six Commensal Fecal and Six Mastitis-Associated Escherichia coli Strains of Bovine Origin: TABLE 1
  33. Bacterial Suppression of RNA Polymerase II-Dependent Host Gene Expression
  34. Uropathogenic E. coli Exploit CEA to Promote Colonization of the Urogenital Tract Mucosa
  35. Escherichia coli: an old friend with new tidings
  36. Asymtomatic Bacteriuria as a Model to Study the Coevolution of Hosts and Bacteria
  37. Primary Amine Oxidase of Escherichia coli Is a Metabolic Enzyme that Can Use a Human Leukocyte Molecule as a Substrate
  38. In Vivo Consumption of Cranberry Exerts ex Vivo Antiadhesive Activity against FimH-Dominated Uropathogenic Escherichia coli: A Combined in Vivo, ex Vivo, and in Vitro Study of an Extract from Vaccinium macrocarpon
  39. Virulence from vesicles: Novel mechanisms of host cell injury by Escherichia coli O104:H4 outbreak strain
  40. Das bililäre Mikrobiom bei hepatobiliären Erkrankungen
  41. 10.1016/j.tube.2014.12.007
  42. Sa1328 Analysis of the Human Biliary Microbiome and Its Alterations in Biliary Tract Diseases
  43. Complete Genome Sequences of Escherichia coli Strains 1303 and ECC-1470 Isolated from Bovine Mastitis
  44. Genomic Avenue to Avian Colisepticemia
  45. Mobile genetic elements and pathogenicity islands encoding bacterial toxins
  46. List of Contributors
  47. Characterization of Urinary Tract Infection-Associated Shiga Toxin-Producing Escherichia coli
  48. Fur Is the Master Regulator of the Extraintestinal Pathogenic Escherichia coli Response to Serum
  49. Prevalence of autotransporters in Escherichia coli: what is the impact of phylogeny and pathotype?
  50. Prevalence and persistence of Escherichia coli in the airways of cystic fibrosis patients—An unrecognized CF pathogen?
  51. The Contribution of Pathogenicity Islands to the Evolution of Bacterial Pathogens
  52. Impact of Genome Plasticity on Adaptation of Escherichia coli during Urinary Bladder Colonization
  53. α-Haemolysin ofEscherichia coliin IBD: a potentiator of inflammatory activity in the colon
  54. Rare Emergence of Symptoms during Long-Term Asymptomatic Escherichia coli 83972 Carriage without an Altered Virulence Factor Repertoire
  55. Heteropathogenic virulence and phylogeny reveal phased pathogenic metamorphosis inEscherichia coliO2:H6
  56. Characterization of Escherichia coli Isolates from Hospital Inpatients or Outpatients with Urinary Tract Infection
  57. The Carbon Storage Regulator (Csr) System Exerts a Nutrient-Specific Control over Central Metabolism in Escherichia coli Strain Nissle 1917
  58. Sequence Variability of P2-Like Prophage Genomes Carrying the Cytolethal Distending Toxin V Operon in Escherichia coli O157
  59. Bacterial control of host gene expression through RNA polymerase II
  60. The long polar fimbriae operon and its flanking regions in bovine Escherichia coli O157:H43 and STEC O136:H12 strains
  61. Phylogenetic group-associated differences in regulation of the common colonization factor Mat fimbria inEscherichia coli
  62. E. coli as an All-Rounder: The Thin Line Between Commensalism and Pathogenicity
  63. Between Pathogenicity and Commensalism
  64. E. coli as an All-Rounder: The Thin Line Between Commensalism and Pathogenicity
  65. Between Pathogenicity and Commensalism
  66. Evolution und Infektionsbiologie der mit dem hämolytisch-urämischen Syndrom (HUS) assoziierten E.  coli (HUSEC)
  67. Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity
  68. Genetic and phylogenetic analysis of avian extraintestinal and intestinalEscherichia coli
  69. The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak
  70. Genome Plasticity and Infectious Diseases
  71. The fimbriae activator MatA switches off motility in Escherichia coli by repression of the flagellar master operon flhDC
  72. Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae
  73. Climate change and infectious diseases – Impact of global warming and climate change on infectious diseases: Myth or reality?
  74. Variation in endogenous oxidative stress in Escherichia coli natural isolates during growth in urine
  75. What defines extraintestinal pathogenic Escherichia coli?
  76. 9th International Meeting on Microbial Epidemiological Markers
  77. Comparison of Asymptomatic Bacteriuria Escherichia coli Isolates from Healthy Individuals versus Those from Hospital Patients Shows that Long-Term Bladder Colonization Selects for Attenuated Virulence Phenotypes
  78. Acute Escherichia coli Prostatitis in Previously Health Young Men: Bacterial Virulence Factors, Antimicrobial Resistance, and Clinical Outcomes
  79. The lipopolysaccharide of the mastitis isolate Escherichia coli strain 1303 comprises a novel O-antigen and the rare K-12 core type
  80. Chromosomal instability in enterohaemorrhagic Escherichia coli O157:H7: impact on adherence, tellurite resistance and colony phenotype
  81. Mobilisation and remobilisation of a large archetypal pathogenicity island of uropathogenic Escherichia coli in vitro support the role of conjugation for horizontal transfer of genomic islands
  82. Pathogen Specific, IRF3-Dependent Signaling and Innate Resistance to Human Kidney Infection
  83. Pathogenomic comparison of human extraintestinal and avian pathogenic Escherichia coli – Search for factors involved in host specificity or zoonotic potential
  84. Host Imprints on Bacterial Genomes—Rapid, Divergent Evolution in Individual Patients
  85. Editorial
  86. Bacterial genome plasticity and its impact on adaptation during persistent infection
  87. Mat fimbriae promote biofilm formation by meningitis-associated Escherichia coli
  88. Genome dynamics and its impact on evolution of Escherichia coli
  89. Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli
  90. Differential effects and interactions of endogenous and horizontally acquired H‐NS‐like proteins in pathogenic Escherichia coli
  91. Safety of Probiotic Escherichia coli Strain Nissle 1917 Depends on Intestinal Microbiota and Adaptive Immunity of the Host
  92. Virulenzfaktoren uropathogener Erreger
  93. Differential effects and interactions of endogenous and horizontally acquired H-NS-like proteins in pathogenicEscherichia coli
  94. High-throughput microarray technology in diagnostics of enterobacteria based on genome-wide probe selection and regression analysis
  95. Cell Wall Structure and Pathogenicity
  96. O-acetyltransferase geneneuOis segregated according to phylogenetic background and contributes to environmental desiccation resistance inEscherichia coliK1
  97. Vacuolisation of human microvascular endothelial cells by enterohaemorrhagic Escherichia coli
  98. Genetic Structure and Distribution of the Colibactin Genomic Island among Members of the Family Enterobacteriaceae
  99. Impact of O-glycosylation on the molecular and cellular adhesion properties of the Escherichia coli autotransporter protein Ag43
  100. Analysis of the sfaXII locus in the Escherichia coli meningitis isolate IHE3034 reveals two novel regulatory genes within the promoter-distal region of the main S fimbrial operon
  101. Adaptation of Pathogenic E. coli to Various Niches: Genome Flexibility is the Key
  102. “Gently Rough”: The Vaccine Potential of aSalmonella entericaRegulatory Lipopolysaccharide Mutant
  103. Cytolethal Distending Toxin Type I and Type IV Genes Are Framed with Lambdoid Prophage Genes in Extraintestinal Pathogenic Escherichia coli
  104. Targeting virulence traits: potential strategies to combat extraintestinal pathogenic E. coli infections
  105. Genotyping DNA chip for the simultaneous assessment of antibiotic resistance and pathogenic potential of extraintestinal pathogenic Escherichia coli
  106. Pathogenomics: An updated European Research Agenda
  107. Genomic fluidity and pathogenic bacteria: applications in diagnostics, epidemiology and intervention
  108. Characterisation of Escherichia coli strains involved in transcytosis across gut epithelial cells exposed to metabolic and inflammatory stress
  109. Delineation of the recombination sites necessary for integration of pathogenicity islands II and III into the Escherichia coli 536 chromosome
  110. Die Biofilm-Bildung und ihre Bedeutung bei Harnwegsinfektionen
  111. Molecular Basis of Commensalism in the Urinary Tract: Low Virulence or Virulence Attenuation?
  112. Aspects of genome plasticity in pathogenic Escherichia coli
  113. Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli
  114. Escherichia�coli ?-haemolysin induces focal leaks in colonic epithelium: a novel mechanism of bacterial translocation
  115. tDNA locus polymorphism and ecto-chromosomal DNA insertion hot-spots are related to the phylogenetic group of Escherichia coli strains
  116. Down-Regulation of Key Virulence Factors Makes the Salmonella enterica Serovar Typhimurium rfaH Mutant a Promising Live-Attenuated Vaccine Candidate
  117. Tumor Necrosis Factor Alpha- and Inducible Nitric Oxide Synthase-Producing Dendritic Cells Are Rapidly Recruited to the Bladder in Urinary Tract Infection but Are Dispensable for Bacterial Clearance
  118. How to become a uropathogen: Comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains
  119. Escherichia coli Induces DNA Double-Strand Breaks in Eukaryotic Cells
  120. Role of Histone-Like Proteins H-NS and StpA in Expression of Virulence Determinants of Uropathogenic Escherichia coli
  121. Role of pathogenicity island-associated integrases in the genome plasticity of uropathogenic Escherichia coli strain 536
  122. Both α-haemolysin determinants contribute to full virulence of uropathogenic Escherichia coli strain 536
  123. Pathogenomics of Escherichia coli and Shigella Species
  124. Active Cytotoxic Necrotizing Factor 1 Associated with Outer Membrane Vesicles from Uropathogenic Escherichia coli
  125. Demonstration of regulatory cross-talk between P fimbriae and type 1 fimbriae in uropathogenic Escherichia coli
  126. Glycosylation of the Self-Recognizing Escherichia coli Ag43 Autotransporter Protein
  127. The Transcriptional Antiterminator RfaH Represses Biofilm Formation in Escherichia coli
  128. Pathogenomics
  129. Mobile genetic elements and pathogenicity islands encoding bacterial toxins
  130. (Patho-)Genomics of Escherichia coli
  131. Regulation of type 1 fimbriae synthesis and biofilm formation by the transcriptional regulator LrhA of Escherichia coli
  132. Presence and Characterization of a Mosaic Genomic Island Which Distinguishes Sorbitol-Fermenting Enterohemorrhagic Escherichia coli O157:H− from E. coli O157:H7
  133. Transcriptional regulation through RfaH contributes to intestinal colonization by Escherichia coli
  134. Characterization of the flexible genome complement of the commensal Escherichia coli strain A0 34/86 (O83 : K24 : H31)
  135. Novel multivalent mannose compounds and their inhibition of the adhesion of type 1 fimbriated uropathogenic E. coli
  136. The Pathogenicity Island-Associated K15 Capsule Determinant Exhibits a Novel Genetic Structure and Correlates with Virulence in Uropathogenic Escherichia coli Strain 536
  137. Analysis of the Genome Structure of the Nonpathogenic Probiotic Escherichia coli Strain Nissle 1917
  138. Oral Immunization with an rfaH Mutant Elicits Protection against Salmonellosis in Mice
  139. Instability of Pathogenicity Islands in Uropathogenic Escherichia coli 536
  140. Excision of the high-pathogenicity island of Yersinia pseudotuberculosis requires the combined actions of its cognate integrase and Hef, a new recombination directionality factor
  141. Genomic islands in pathogenic and environmental microorganisms
  142. Pathogenicity Islands and Their Role in Bacterial Virulence and Survival
  143. Pathogenomics of mobile genetic elements of toxigenic bacteria
  144. The Molecular Basis of Infectious Diseases: Pathogenicity Islands and Other Mobile Genetic Elements
  145. Prokaryotic Chromosomes and Disease
  146. Bacteroides vulgatus protects against escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice
  147. Cytolethal Distending Toxin Gene Cluster in Enterohemorrhagic Escherichiacoli O157:H− and O157:H7: Characterization and Evolutionary Considerations
  148. Commensal bacteria make a difference
  149. Analysis of Genome Plasticity in Pathogenic and Commensal Escherichia coli Isolates by Use of DNA Arrays
  150. A Single Nucleotide Exchange in the wzy Gene Is Responsible for the Semirough O6 Lipopolysaccharide Phenotype and Serum Sensitivity of Escherichia coli Strain Nissle 1917
  151. Genetic Structure and Distribution of Four Pathogenicity Islands (PAI I536 to PAI IV536) of Uropathogenic Escherichia coli Strain 536
  152. Loss of Regulatory Protein RfaH Attenuates Virulence of Uropathogenic Escherichia coli
  153. Pathogenicity islands of uropathogenic E. coli and the evolution of virulence
  154. Efficient expression of the α-haemolysin determinant in the uropathogenic Escherichia coli strain 536 requires the leuX -encoded tRNA 5 Leu
  155. Virulence factors of uropathogens
  156. Identification and distribution of the enterohemorrhagic Escherichia coli factor for adherence (efa1) gene in sorbitol- fermenting Escherichia coli O157 : H−
  157. Genome Plasticity in Pathogenic and Nonpathogenic Enterobacteria
  158. Genome Plasticity in Pathogenic and Nonpathogenic Enterobacteria
  159. EVOLUTION OF MICROBIAL PATHOGENS
  160. Identification and Characterization of a Novel Genomic Island Integrated at selC in Locus of Enterocyte Effacement-Negative, Shiga Toxin-Producing Escherichia coli
  161. Whole genome plasticity in pathogenic bacteria
  162. S-Fimbria-Encoding Determinant sfaI Is Located on Pathogenicity Island III536 of UropathogenicEscherichia coli Strain 536
  163. Regulation of the tRNA 5 Leu -encoding gene leuX that is associated with a pathogenicity island in the uropathogenic Escherichia coli strain 536
  164. A subtractive hybridisation analysis of genomic differences between the uropathogenic E. coli strain 536 and the E. coli K-12 strain MG1655
  165. Expression of Hemin Receptor Molecule ChuA Is Influenced by RfaH in Uropathogenic Escherichia coliStrain 536
  166. The Pathogenicity Islands (PAIs) of the Uropathogenic Escherichia coli Strain 536: Island Probing of PAI II 536
  167. Pathogenicity islands and phage conversion: evolutionary aspects of bacterial pathogenesis
  168. Toxin genes on pathogenicity islands: impact for microbial evolution
  169. Evolution of microbial pathogens
  170. Influence of pathogenicity islands and the minor leuX-encoded tRNA5Leu on the proteome pattern of the uropathogenic Escherichia coli strain 536
  171. The leuX -encoded tRNA 5 Leu but not the pathogenicity islands I and II influence the survival of the uropathogenic Escherichia coli strain 536 in CD-1 mouse bladder mucus in the stationary phase
  172. The leuX-encoded tRNA5Leu but not the pathogenicity islands I and II influence the survival of the uropathogenic Escherichia coli strain 536 in CD-1 mouse bladder mucus in the stationary phase
  173. The Pai‐associated leuX specific tRNA Leu 5 affects type 1 fimbriation in pathogenic Escherichia coli by control of FimB recombinase expression
  174. Purification and characterization of a membrane-bound hydrogenase from Sporomusa sphaeroides involved in energy-transducing electron transport
  175. How Bacterial Pathogens were Constructed
  176. Analysis of Pathogenicity Islands of STEC
  177. Pathogenomics: Identification of Novel Drug Targets and Vaccine Candidates in Bacteria
  178. Pathogenicity Islands of Uropathogence E. Coli and Evolution of Virulence
  179. Analysis of the Hemolysin Determinants of the Uropathogenic Escherichia coli Strain 536